| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 672 |
| 1 | RANIBIZUMAB | 354 |
| 2 | INSULIN GLARGINE | 340 |
| 3 | ASPIRIN | 320 |
| 4 | BEVACIZUMAB | 317 |
| 5 | PREDNISONE | 313 |
| 6 | ASPIRIN 325 MG | 308 |
| 7 | ASPIRIN 81 MG | 308 |
| 8 | INSULIN LISPRO | 273 |
| 9 | METHOTREXATE SODIUM | 271 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERTEPORFIN FOR INJECTION | 66 | 0.0446 |
| 1 | APRACLONIDINE | 3 | 0.0270 |
| 2 | CYCLOPENTOLATE HYDROCHLORIDE | 17 | 0.0258 |
| 3 | ERDAFITINIB | 24 | 0.0192 |
| 4 | CEFUROXIME SODIUM | 23 | 0.0188 |
| 5 | PEMIGATINIB | 16 | 0.0188 |
| 6 | TOBRAMYCIN AND DEXAMETHASONE | 48 | 0.0144 |
| 7 | SELUMETINIB | 23 | 0.0137 |
| 8 | RANIBIZUMAB | 354 | 0.0134 |
| 9 | BINIMETINIB | 96 | 0.0121 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1020 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 806 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 679 |
| 3 | Insulin Analog [EPC] | 625 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 326 |
| 5 | Kinase Inhibitor [EPC] | 309 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 297 |
| 7 | GLP-1 Receptor Agonist [EPC] | 269 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 264 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 254 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 66 | 0.0170 |
| 1 | Diagnostic Dye [EPC] | 5 | 0.0077 |
| 2 | Antiseptic [EPC] | 26 | 0.0060 |
| 3 | Endoglycosidase [EPC] | 9 | 0.0049 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 806 | 0.0044 |
| 5 | Insulin [EPC] | 163 | 0.0035 |
| 6 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 7 | Anticholinergic [EPC] | 49 | 0.0030 |
| 8 | Carbonic Anhydrase Inhibitor [EPC] | 58 | 0.0029 |
| 9 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |